Persistence of CD33 expression at relapse in CD33+ acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease

被引:15
|
作者
Chevallier, Patrice [1 ]
Robillard, Nelly [1 ]
Ayari, Sameh [1 ]
Guillaume, Thierry [1 ]
Delaunay, Jacques [1 ]
Mechinaud, Francoise [1 ]
Avet-Loiseau, Herve [1 ]
Mohty, Mohamad [1 ]
Harousseau, Jean-Luc [1 ]
Garand, Richard [1 ]
机构
[1] Ctr Hosp Univ, Dept Haematol, Nantes, France
关键词
acute myeloid leukaemia; Gemtuzumab; Mylotarg; CD33; phenotype;
D O I
10.1111/j.1365-2141.2008.07153.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:744 / 746
页数:3
相关论文
共 50 条
  • [31] Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy
    Khogeer, Haitham
    Rahman, Haitham
    Jain, Nitin
    Angelova, Evgeniya A.
    Yang, Hong
    Quesada, Andres
    Ok, Chi Y.
    Sui, Dawen
    Wei, Peng
    Al Fattani, Areej
    Pierce, Sherry
    Loghavi, Sanam
    Lamb, Audrey
    Hu, Peter
    Thakral, Beenu
    Kanagal-Shamanna, Rashmi
    Jorgensen, Jeffrey L.
    Jabbour, Elias J.
    Kantarjian, Hagop M.
    Medeiros, L. Jeffrey
    Khoury, Joseph D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (04) : 538 - 548
  • [32] CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
    Molica, Matteo
    Perrone, Salvatore
    Mazzone, Carla
    Niscola, Pasquale
    Cesini, Laura
    Abruzzese, Elisabetta
    de Fabritiis, Paolo
    CANCERS, 2021, 13 (13)
  • [33] Long-Term Disease-Free Survival After Gemtuzumab, Intermediate-Dose Cytarabine, and Mitoxantrone in Patients With CD33+ Primary Resistant or Relapsed Acute Myeloid Leukemia
    Chevallier, Patrice
    Delaunay, Jacques
    Turlure, Pascal
    Pigneux, Arnaud
    Hunault, Mathilde
    Garand, Richard
    Guillaume, Thierry
    Avet-Loiseau, Herve
    Dmytruk, Nathalia
    Girault, Stephane
    Milpied, Noel
    Ifrah, Norbert
    Mohty, Mohamad
    Harousseau, Jean-Luc
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) : 5192 - 5197
  • [34] Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
    Pollard, Jessica A.
    Alonzo, Todd A.
    Loken, Michael
    Gerbing, Robert B.
    Ho, Phoenix A.
    Bernstein, Irwin D.
    Raimondi, Susana C.
    Hirsch, Betsy
    Franklin, Janet
    Walter, Roland B.
    Gamis, Alan
    Meshinchi, Soheil
    BLOOD, 2012, 119 (16) : 3705 - 3711
  • [35] Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex
    Walke, Douglas G.
    Whetzel, Alexis M.
    Serrano, Geidy
    Sue, Lucia I.
    Beach, Thomas G.
    Lue, Lih-Fen
    NEUROBIOLOGY OF AGING, 2015, 36 (02) : 571 - 582
  • [36] PROGNOSTIC-SIGNIFICANCE OF CD34 EXPRESSION AND CD33/CD13 RATIO IN ACUTE MYELOID-LEUKEMIA
    LEVIS, A
    DEPAOLI, L
    ISABELLA, N
    RESEGOTTI, L
    HAEMATOLOGICA, 1993, 78 (06) : 420 - 420
  • [37] Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin
    I Iacobucci
    A Lonetti
    A Candoni
    M Sazzini
    C Papayannidis
    S Formica
    E Ottaviani
    A Ferrari
    A Michelutti
    E Simeone
    A Astolfi
    M C Abbenante
    S Parisi
    F Cattina
    M Malagola
    D Russo
    D Damiani
    F Gherlinzoni
    M Gottardi
    M Baccarani
    R Fanin
    G Martinelli
    The Pharmacogenomics Journal, 2013, 13 : 335 - 341
  • [38] Quantification of CD33 molecules on human acute myeloid and lymphoid leukemias.
    De Propris, MS
    Guarini, A
    Lisci, A
    Metoni, G
    Giona, F
    Tafuri, A
    Foa, R
    BLOOD, 2002, 100 (11) : 240B - 240B
  • [39] CD33 Targeted gd T cells for Treatment of Acute Myeloid Leukemia
    Boucher, Justin C.
    Austin, Anna L.
    Kostenko, Elena
    Reid, Kayla
    Nagy, Mate Z.
    Davila, Marco L.
    Guevara-Patino, Jose A.
    Bejanyan, Nelli
    MOLECULAR THERAPY, 2024, 32 (04) : 633 - 634
  • [40] Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression
    Chevallier, Patrice
    Mahe, Beatrice
    Garand, Richard
    Talmant, Pascaline
    Harousseau, Jean-Luc
    Delaunay, Jacques
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 209 - 211